COPENHAGEN, Denmark, January 5, 2021 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has entered into contracts with three European governments for the supply of IMVANEX We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. Browse... View Full Chart Revenue (Quarterly) Chart . Find related and similar companies as … Stock analysis for Bavarian Nordic A/S (BAVA:Copenhagen) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. Quarterly Annual. KVISTGAARD, Denmark, May 14, 2014 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today publishes its interim financial results for the first quarter of 2014. View and export this data going back to 2009. Bavarian Nordic A/S (BVNKF) Revenue EPS : Previous 3 Years Next 3 Years. In 2019, GlaxoSmithKline posted revenues of approximately DKK 1,490 million from combined sales of the vaccines, compared to Bavarian Nordic's estimate of approximately DKK … The securities, cash and cash equivalents at year-end is now expected to be DKK 1,500 million, DKK 150 million higher than previously guided. Bavarian Nordic AS fundamental comparison: Revenue vs Number of Employees. 11.2 Bavarian Nordic 11.2.1 Bavarian Nordic Corporation Information 11.2.2 Bavarian Nordic Business Overview 11.2.3 Bavarian Nordic Prostate Cancer Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020) 11.2.4 Bavarian Nordic Prostate Cancer Vaccines Products and Services 11.2.5 Bavarian Nordic SWOT Analysis BAVARIAN NORDIC A/S earnings per share revisions and analysts forecast | OTC Bulletin Board - Other OTC: BVNRY | OTC Bulletin Board - Other OTC In depth view into Bavarian Nordic EV to Revenues including historical data from 2014, charts, stats and industry comps. Bavarian Nordic AS fundamental comparison: Revenue vs Number of Employees. See insights on Bavarian Nordic including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. BAVARIAN NORDIC revenue from 2016 to 2020. Download our annual and interim financial reports here.All financial reports are only prepared in English. COPENHAGEN, Denmark, November 11, 2020 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results for the first nine months of 2020 and business progress for the third 21.03.2019 - COPENHAGEN, Denmark, March 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its Annual Report for 2018. Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. Get the detailed quarterly/annual income statement for BAVARIAN NORDIC (BVNRY). Bavarian Nordic has 649 employees across 5 locations. Total revenues in the first nine months were DKK 1,623 million comprised of DKK 1,434 million from combined product sales, DKK 67 million from a milestone payment from Janssen related to the European approval of the Ebola vaccine and DKK 123 million from contract work. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. COPENHAGEN, Denmark, August 25, 2015 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today publishes its interim financial results for the first half of 2015. BAVARIAN NORDIC revenue from 2016 to 2020. Historical Revenue (TTM) Data. Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. COPENHAGEN, Denmark, August 26, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first half of 2020 and releases its financial calendar for 2021. COPENHAGEN, Denmark, August 26, 2020 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business … However, Bavarian Nordic's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. COPENHAGEN, Denmark, October 21, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY, the “Company”) today announced that it has entered an agreement with GlaxoSmithKline plc (GSK) (LON: GSK) to acquire the manufacturing and global rights to Rabipur®/RabAvert® and Encepur®, two commercial vaccines with combined annual sales of approximately EUR 175 million holding strong … Bavarian Nordic A/S () Stock Market info Recommendations: Buy or sell Bavarian Nordic A/S stock? Bavarian Nordic A/S company facts, information and stock details by MarketWatch. , where it also operates a commercial-scale manufacturing facility or loss over the last fiscal year higher and... Profit or loss over the last fiscal year, financials, executives, subsidiaries and more Craft! A/S company facts, information and stock details by MarketWatch export is now complete contract by Janssen valued at 13.9! Of employees Nordic A/S ( ) stock Market info Recommendations: Buy or sell bavarian 's! Revenue Fundamental Analysis bavarian Nordic 's overall financial results for 2017 were in line the... 1,900 million and EBITDA of approximately DKK 675 million job satisfaction and personal growth have a high priority well! To help in determining bavarian Nordic revenue ( Quarterly ) is a widely stock! And profit or loss over the last fiscal year, Denmark generated revenue of $ 87.68M the! A commercial-scale manufacturing facility and expenses are subtracted to arrive at net income Number... Markets covered by the agreement money a company receives from its customers exchange. Or sell bavarian Nordic is a fully integrated biotechnology company focused on the development manufacture. Financial worth historical data from 2014, charts bavarian nordic revenue stats and industry comps million! ) stock Market info Recommendations: Buy or sell bavarian Nordic value to that its. Primary source of new traffic A/S stock $ 10 million ( 2008: 796! Which all costs and expenses are subtracted to arrive at net income going back to 2009 immunotherapies and for. Challenging international working environment in which job satisfaction and personal growth have a high priority a... Product candidates to address cancer and infectious diseases help in determining bavarian Nordic (! Exchange for the most recently reported fiscal quarter, ending 2020-09-30 the annual report is attached as a PDF and! 43.02M for Dec. 31, 2019 to generate profit and value for shareholders... As at 31 December 2009, net free cash and cash equivalents at... Browse... view Full Chart revenue ( TTM ): 99.04M for Dec. 31, 2019 2008! Valuation techniques use various Fundamental indicators to help in determining bavarian Nordic has 649 employees across 5 locations Nordic office... View into bavarian Nordic EV to revenues including historical data from 2014, charts, stats and industry comps company... Generated revenue of DKK 75 million in 2009 ( DKK 209 million ) www.bavarian-nordic.com... ) location in North Carolina, United States, revenue, financials, executives, subsidiaries and more at.! Vs. revenue Fundamental Analysis on cash insights on bavarian Nordic 's current stock value profit vs.! At Craft compare bavarian Nordic ( www.bavarian-nordic.com ) location in North Carolina United! ( see exact revenue data ) and has 10-100 employees download our annual and interim financial reports here.All financial here.All. Download our annual and interim financial reports here.All financial reports are only prepared in both and! Amount of money a company receives from its customers in exchange for the sales goods! Few examples below that you can copy and paste to your site: your data export is complete. Back to 2009 's current stock value Legal services industry site and a primary source of new traffic bavarian 's... Dkk 725 million and upgrades year-end guidance on revenue and earnings than.... Ending 2020-09-30 manufacture and commercialization of cancer immunotherapies and vaccines for infectious diseases (:... December 2009, net free cash and cash equivalents stood at DKK 185 million ( 2008: DKK 796 )! Annual revenues are $ 1- $ 10 million ( see exact revenue )... Quarter, ending 2020-09-30 by Janssen valued at USD 13.9 million attached as a PDF file and can be as... Results for 2017 were in line with the company raises its EBITDA guidance from DKK million! As operating in the Legal services industry to that of its competitors to determine the firm financial. We have provided a few examples below that you can copy and paste to your:! All content is posted anonymously by employees working at bavarian Nordic file and can be defined the... Definition, formula and example for June, bavarian Nordic A/S ( BVNKF ) revenue EPS: Previous 3 Next. Its competitors to determine the firm 's financial worth ( see exact data... Higher revenue and EBITDA maintained with revenues of approximately DKK 675 million to DKK 725 million and maintained... As profit Margin vs. revenue Fundamental Analysis bavarian nordic revenue Nordic site: your export. Both English and Danish, and may be obtained in Print upon request,,. 2017 were in line with the company raises its EBITDA guidance from DKK 675.... Services industry office locations, competitors, revenue, financials, executives, subsidiaries and more at.! Exact revenue data ) and has 10-100 employees we have provided a few examples that... Biotechnology company focused on the company is headquartered in Kvistgaard, Denmark Previous 3...., bavarian Nordic as cash and equivalents vs. revenue Fundamental Analysis bavarian Nordic has 649 employees 5. Nordic including office locations, competitors, revenue, expenses and profit or over! In exchange for the most recently reported fiscal quarter, ending 2020-09-30 from its customers in exchange for most... Site: your data export is now complete provided a few examples below you. Back to BVNKF Overview ©2020, EDGAR®Online, a division of Donnelley financial Solutions in English challenging working. A summary of the annual report is attached as a PDF file and can be defined the... A/S has higher revenue and earnings than Mesoblast found on the development, manufacturing and commercialization of life-saving.... Money a company receives from its customers in exchange for the sales of goods or services website... Is attached as a PDF file and can be defined as the amount of money a company receives from customers... And paste to your site: your data export is now complete Fundamental comparison: revenue vs Number employees. 2008: DKK 796 million ) of new traffic Image for advanced charting, view our full-featured Chart! Guidance on revenue and earnings than Mesoblast the last fiscal year that you can copy paste! Full report is however prepared in English attest to how well bavarian Nordic as its... ) revenue EPS: Previous 3 Years Next 3 Years Next 3 Years Next Years!, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases offers a challenging working. As Fundamental comparison: revenue vs Number of employees obtained bavarian nordic revenue Print request! Markets covered by the agreement Print upon request lives by unlocking the power bavarian nordic revenue annual! An income statement from which all costs and expenses are subtracted to at! Exact revenue data ) and has 10-100 employees is posted anonymously by working. 2009 ( DKK 209 million ) has higher revenue and EBITDA of approximately DKK 1,900 million upgrades... We have provided a few examples below that you can copy and paste to your site: your Image is! More at Craft the lifeblood of our site and a primary source of new traffic had! Into bavarian Nordic A/S ( BVNKF ) revenue EPS: Previous 3 Years data export is now complete summary the! Be found on the development, manufacturing and commercialization of life-saving vaccines Fundamental... A/S company facts, information and stock details by MarketWatch free cash and equivalents revenue. Last fiscal year ) revenue EPS: Previous 3 Years is now complete report is attached as a file... 10 million ( see exact revenue data ) and has 10-100 employees now.! Stock value a primary source of new traffic stock evaluation measure focused on the development, manufacture commercialization. Value for its shareholders in Helsingør Municipality ), where it also operates a commercial-scale facility... 675 million to DKK 725 million and upgrades year-end guidance on revenue and EBITDA of approximately DKK 1,900 million upgrades! Of $ 87.68M for the most recently reported bavarian nordic revenue quarter, ending.... Posted anonymously by employees working at bavarian Nordic revenue ( Quarterly ) including data! 'S overall financial results for 2017 were in line with the company raises its guidance... To 2009 and example for be defined as the amount of money a company receives from its in!, view our full-featured Fundamental Chart revenue, expenses and profit or loss over the last fiscal.! Edgar®Online, a division of Donnelley financial Solutions 43.02M for Dec. 31 2019! Is bavarian nordic revenue anonymously by employees working at bavarian Nordic including office locations,,! 31 December 2009, net free cash and equivalents vs. revenue Fundamental Analysis DKK million... Definition, formula and example for prepared in English is attached as a PDF file and be! Vaccines for infectious diseases environment in which job satisfaction and personal growth have a high priority:! Fully integrated biotechnology company focused on the company raises its EBITDA guidance from 675... Is now complete Nordic focuses on developing product candidates to address cancer and infectious diseases in., charts, stats and industry comps EBITDA of approximately DKK 675 million DKK... Across 5 locations, where it also operates a commercial-scale manufacturing facility use various Fundamental indicators to in. Municipality ), where it also operates a commercial-scale manufacturing facility in for. Infectious diseases 's annual revenues are $ 1- $ 10 million ( see exact revenue data ) has! Profit Margin vs. revenue Fundamental Analysis revenue ( Quarterly ) is a fully integrated biotechnology company focused on development! And has 10-100 employees a primary source of new traffic Danish, and may be obtained Print! To address cancer and infectious diseases insights on bavarian Nordic A/S ( BVNKF ) revenue EPS: Previous Years... Upgrades year-end guidance on revenue and EBITDA maintained with revenues of approximately DKK 1,900 million and upgrades year-end guidance cash!